期刊文献+

粘细菌生物活性产物及其应用研究进展 被引量:2

Research progress in bioactive products of myxobacteria and their applications
原文传递
导出
摘要 粘细菌(myxobacteria)是一类具有多细胞群体行为特征的药源微生物类群。粘细菌能通过次级代谢产生大量结构新颖并具有生物活性的小分子天然产物,还能分泌种类、功能丰富多样的酶类。这些生物活性产物使粘细菌不仅具有重要的研究价值,还有广泛的应用前景。然而,资源挖掘困难、次级代谢产物得率低等制约因素的存在严重阻碍了粘细菌的研究和应用。本文主要对粘细菌的生物学特征、生物活性产物、生物合成调控及在医疗、农业和食品上的应用进行归纳总结,并结合已有成果对粘细菌研究存在的问题提出可能的对策和展望,为今后粘细菌的深入研究和资源开发利用提供参考。 Myxobacteria are a group of medical microorganisms showing complex multicellular behaviors.On one hand,they produce a variety of natural bioactive compounds with novel structures through secondary metabolism.On the other hand,they can secrete diverse functional enzymes.Therefore,myxobacteria are valuable for basic research and applications.However,the research on them has been impeded by the difficulties in resource mining and the low yield of secondary metabolites.This review introduces myxobacteria in terms of the biological characteristics,bioactive products,regulation on biosynthesis and applications in medicine,agriculture and food industry.Based on available results,the problems in the research on myxobacteria and the possible countermeasures are presented.This review is expected to provide reference for the in-depth research and the resource development and utilization of myxobacteria.
作者 翟辰欣 吕莹 汪绍杰 樊博 王泽建 吴杰群 梁剑光 ZHAI Chenxin;LÜYing;WANG Shaojie;FAN Bo;WANG Zejian;WU Jiequn;LIANG Jianguang(School of Pharmacy and School of Biological and Food Engineering,Changzhou University,Changzhou 213164,Jiangsu,China;School of Biotechnology,East China University of Science and Technology,Shanghai 200237,China;College of Pharmaceutical Science,Zhejiang University of Technology,Hangzhou 310014,Zhejiang,China)
出处 《微生物学通报》 CAS CSCD 北大核心 2023年第9期4237-4259,共23页 Microbiology China
基金 国家重点研发计划(2021YFC2101000) 国家自然科学基金(32071471) 江苏省研究生科研与实践创新计划(SJCX23_1456)。
关键词 粘细菌 生物活性产物 生物合成 应用 myxobacteria bioactive products biosynthesis applications
  • 相关文献

参考文献13

二级参考文献138

  • 1韩斌,韩峰,董艳峰.青霉素高产菌种的推理选育[J].中国抗生素杂志,2004,29(7):433-434. 被引量:7
  • 2朱豫,盛艳娟,黄波.大剂量甲基泼尼松龙对大鼠视神经挤压伤后RGC凋亡的影响[J].眼科研究,2003,21(6):582-584. 被引量:17
  • 3金志华,金一平,宋友礼.Avermectin产生菌异亮氨酸诱导变种的选育[J].中国抗生素杂志,1997,22(2):84-86. 被引量:9
  • 4Dawid W. Biology and global distribution of myxobacteria in soils. FEMS Microbiol Rev, 2000, 24(4): 403-427.
  • 5Shirnkets L J, Dworkin M, Reichenbach H. The Myxobacteria. The Prokaryotes, New York: Springer, 2005: 1-94.
  • 6Gerth K, Pradella S, Perlova O, et al. Myxobacteria: proficient producers of novel natural products with various biological activities-past and future bioteehnological aspects with the focus on the genus Sorangium. J Biotechnol, 2003, 106(2 3): 233-253.
  • 7Wenzel S C, Muller R. Myxobacteria-'microbial factories' for the production of bioactive secondary metabolites. Mol Biosyst, 2009, 5(6): 567-574.
  • 8Pronzato P. New therapeutic options for chemotherapy-resistant metastatic breast cancer: The epothilones. Drugs, 2008, 68 (2): 139-146.
  • 9Wenzel S C, Muller R. Myxobacterial natural product assembly lines: Fascinating examples of curious biochemistry. Nat Prod Rep, 2007, 24(6): 1211-1224.
  • 10Cane D E, Walsh C T, Khosla C. Harnessing the biosynthetic code: Combinations, permutations, and mutations. Science, 1998, 282(5386): 63-68.

共引文献71

同被引文献12

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部